Surveillance and epidemiology of MRSA bacteraemia in the UK.
about
Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic reviewEpidemiology and Pathogenesis of C. difficile and MRSA in the Light of Current NHS Control Policies: A Policy reviewSurveillance of antibiotic resistanceA timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureusChanging patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period.Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications.Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI.Recent trends in spinal infections: retrospective analysis of patients treated during the past 50 yearsMolecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among patients admitted to adult intensive care units: the STAR*ICU trial.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Relationship between multiple drug resistance and biofilm formation in Staphylococcus aureus isolated from medical and non-medical personnel in Yaounde, Cameroon.Mechanisms of antibiotic resistance in Staphylococcus aureus.High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries.The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji.The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.Resistance pattern of ciprofloxacin against different pathogens.Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.Inhibition of methicillin-resistant Staphylococcus aureus (MRSA) by antimicrobial peptides (AMPs) and plant essential oils.Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis.ANTISTAPHYBASE: database of antimicrobial peptides (AMPs) and essential oils (EOs) against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus.Public reporting: Illumination or shadows?Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance periodBuilding a genomic framework for prospective MRSA surveillance in the United Kingdom and the Republic of Ireland.EMRSA-15 Bacteremia is not Associated with a Worse Outcome Compared with Bacteremia Caused by Multidrug-Resistant MRSA.Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive powerIncreasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England.Curbing the menace of antimicrobial resistance in developing countriesMethicillin-resistant Staphylococcus aureus nasal colonization in a department of pediatrics: a cross-sectional studyVoluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.Methicillin-resistant Staphylococcus aureus: the European landscape.A Heme-responsive Regulator Controls Synthesis of Staphyloferrin B in Staphylococcus aureusEmpirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.The potential of bacteriophage cocktail in eliminating Methicillin-resistant Staphylococcus aureus biofilms in terms of different extracellular matrices expressed by PIA, ciaA-D and FnBPA genes.[Mandatory reporting of antimicrobial-resistant pathogens. What should, what can be achieved? : assessment related to the particular facility seems crucial].The regulation of infection.Trends in paediatric nosocomial bacteraemia in a London tertiary hospital.Antibacterial susceptibility patterns and cross-resistance of methicillin resistant and sensitive staphyloccus aureus isolated from the hospitalized patients in shiraz, iranMethicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns.'Feral' and 'wild'-type methicillin-resistant Staphylococcus aureus in the United Kingdom.
P2860
Q27006781-1BFAB525-E900-43B3-AA47-AE085A791E66Q27022332-DD679D84-EE79-47F6-8038-83C7B4AA536DQ28082571-B86B5B95-358D-41CA-85D0-F00C34E04F4CQ28752649-A172FC18-806C-47F7-8357-E13F792C88BDQ30370523-BB7859AC-2C4F-4F20-BA9E-7A3C722ADF89Q30424717-C2BD2CE1-368F-4628-B91E-E49F392CF226Q33404594-B0BB52D1-73D3-4D17-A35D-E8033E75B2DCQ33788342-7C109B70-0FC3-49C9-844C-AD7A47811B87Q33971523-F203CB98-D0EF-4D49-8A19-2700A9C356AFQ34111161-F2CEDF78-F6AA-45C2-8096-77EB5582712FQ34478074-56BD9FA9-A036-4F6B-B8B7-4A0BB3973A67Q34496815-54D19A29-80A1-48FC-8B0E-7AD619A5537EQ34657311-7EF332AD-15EF-4CC9-945C-4F5B83EB39C9Q34679844-7514F420-EFB9-451C-A65D-31BB58495DDBQ35127286-1611D505-42CE-4F33-AF25-46E6C329788EQ35297286-9B3FBAAB-6B50-464A-8483-7FBE17E8A39EQ35323705-E8B0370C-3889-4FF1-B3B3-2951ADBD10CDQ35839071-050C8BD1-E868-4A41-84C4-89E1086BCC44Q36035761-A36EEE38-4D08-4BFA-9808-295832905836Q36045103-4EC08F27-A6A8-4FE4-B0E9-B620CAB89697Q36145527-B04520D3-42A9-4CF3-A76F-656CC75B42E8Q36171145-596470B4-28F8-4078-ADE7-F360CFB993BFQ36323321-888067F9-B2B5-40D9-A8DC-FA1C43FD594DQ36506761-69A0B8CF-26B5-4023-B5B7-0719B5231BE3Q36735269-5F7661C1-6971-4D42-B8C4-99AC5B062BA2Q36963701-8D97925D-C772-4EAC-8267-5FFB63D92428Q37009085-DE5AE119-D3FB-46B1-8F82-D3E105E6BA64Q37437298-FB5A294E-7E0D-44B9-B3C7-361B291FC29CQ37496842-F2CEEED0-608F-4841-B6B3-F8C6F2D146B6Q37578896-80251134-8347-4A67-918B-D6DE6B409981Q37869257-C97ADABF-74C7-475B-8ED2-B8155E7A0F0CQ40358381-F517295A-E130-4A2B-832C-1055ABC3D24AQ40375415-CD9967FB-9E88-4186-9097-3F78C2ED9B75Q41131819-ACD1DCF1-8DEB-42B8-84F9-400E8AC94AFBQ41697861-B4DFEB45-CBDB-4279-9B4F-6E2B188667A8Q41973761-18A6A249-16F6-405D-8979-C1D12624D1B0Q42255880-A16725ED-1863-4D6A-8CED-8AE88711B025Q42593938-2CA3D1F2-3364-412C-B37B-FD5D0E00DE5BQ42772843-318BB99F-CAE4-412F-8DE9-A975E386DE5AQ43225066-A0B575EC-15BF-4775-8428-F586E37B0A56
P2860
Surveillance and epidemiology of MRSA bacteraemia in the UK.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@ast
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@en
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@nl
type
label
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@ast
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@en
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@nl
prefLabel
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@ast
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@en
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@nl
P2093
P2860
P356
P1476
Surveillance and epidemiology of MRSA bacteraemia in the UK.
@en
P2093
Alan P Johnson
Andrew Pearson
Georgia Duckworth
P2860
P304
P356
10.1093/JAC/DKI266
P407
P577
2005-07-26T00:00:00Z